Promega technology used in the development of vaccines for infectious viral diseases will support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations' (CEPI's ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The Michigan Court of Appeals, in effect, ruled that Chelsea Hospital and the drugmaker, Gilead Sciences Inc., are immune ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there.